The mmimum dose of human chorionic gonadotrophin needed to induce ovulation was determined in hamsters, in which the luteinizing hormone surge was blocked by administration of phenobarbitone. Doses of 1.0, 2.5, 5.0 and 10.0 IV human chorionic gonadotrophin were injected subcutaneously, and 5.0 IV was found to be the minimum dose needed to induce ovulation in all of a group of seven hamsters. When this minimum dose was used to induce ovulation repeatedly, one, two or three times, in groups of seven hamsters the percentages of abnormal eggs seen were 5.3%, 5.6% and 6.4%, respectively. These results indicate that the marked increases in the proportions of abnormal eggs produced when ovulation is repeatedly induced, which have been observed in previous studies, can be prevented by using the minimum effective dose of human chorionic gonadotrophin.
INTRODUCTION
Gonadotrophins such as human chorionic gonadotrophin (hCG) are widely used to treat women with an ovulation disorder.t" The rate of pregnancy resulting from induced ovulation by repeated administration of gonadotrophin is not always high. ' :"
Ovulation induced by hCG produces a number of abnormal unfertilized eggs showing cleavage." We have previously reported that in repeatedly induced ovulation the proportion of abnormal eggs produced in laboratory animals increases.':" Few studies" have explored ways of reducing the numbers of abnormal unfertilized eggs in repeatedly induced ovulation.
The aim of the present study was to investigate whether the percentage of abnormal unfertilized eggs can be reduced in repeatedly induced ovulation by using the minimum dose of hCG. Firstly, the minimum dose of hCG required for induced ovulation was determined in hamsters (experiment 1). Secondly, ovulation was induced one to three times with this minimum dose of hCG, and the percentage of abnormal unfertilized eggs showing cleavage and the ovulation rate were determined (experiment 2).
MATERIALS AND METHODS

ANIMALS
Mature, female golden hamsters, aged 10 -12 weeks, with regular oestrus cycles of 4 days were purchased from a commercial breeder (Saitama Experimental Animal Supply Co. Ltd., Saitama, Japan). Their oestrus cycles were determined by observing post-ovulatory discharge" from the vagina on the morning of the ovulation day. The hamsters were given a standard diet with water ad Jib. The animal room was air-conditioned at 23 ± 2°C, 55 ± 5% relative humidity, with 15 air changes per 23 hour, and illuminated for 14 h/day (05:00 -19:00) with 300 lx daylight fluorescent lamps.
EXPERIMENT 1
Phenobarbitone 100 mg/kg was injected subcutaneously into hamsters at 12.30 on the pro-oestrus day to block the surge of luteinizing hormone and thus block ovulation.":"
Immediately after injection of phenobarbitone, 1.0, 2.5, 5.0 or 10.0 IU of hCG was injected subcutaneously into the hamsters. These amounts of hCG were dissolved in normal saline to yield I-ml preparations. The hamsters in the control groups were injected subcutaneously with 1 ml of normal saline without hCG. The next morning, the hamsters were killed by an overdose of sodium phenobarbitone. The oviducts removed from the animals at laparotomy were sampled, and the numbers of ovulated eggs in the ampulla of the oviduct and their morphological abnormalities were examined by microscope.
EXPERIMENT 2
The minimum dose of hCG effective for induced ovulation was determined in experiment 1 to be 5 IV, and this dose ofhCG was used in experiment 2. At 12.30 on the pro-oestrus day, 100 mg/kg phenobarbitone was injected subcutaneously into the hamsters in the induced ovulation group.
The animals of the induced ovulation group were divided into three subgroups in which injection of 5 IV hCG was performed once, twice or three times. Since the interval of hCG injection was 4 days, the same duration as the hamster's oestrus cycle, the day of hCG injection was the day when Graafian follicles were present in the ovary.
The hamsters in a control group were killed on the morning of the day of observation of post-ovulatory discharge, and the animals in the induced ovulation groups were killed after confirmation of ovulation by a post-ovulatory discharge on the day after hCG injection. The numbers of eggs in the ampulla of the oviduct and their morphological abnormalities were examined as in experiment 1.
STATISTICAL ANALYSIS
The percentages of unfertilized eggs showing abnormal cleavage were analysed by X 2 test, comparing control and treated groups in experiment 2. Differences were considered significant when P-values were < 0.05.
RESULTS
It is clear from the results of experiment 1 ( Table 1) that, of the doses tested, in animals in which the luteinizing hormone surge was blocked by phenobarbitone, 5 IU hCG was the minimum dose needed to induce ovulation in all of the hamsters.
In experiment 2 the total number of eggs ovulated from the seven animals of the intact control group was 121, of which two eggs (1.7%) showed abnormal cleavage ( Table 2 ). The mean numbers of ovulated eggs were similar in the induced ovulation groups and the control group, but the proportion of abnormal unfertilized eggs showing cleavage increased in the induced ovulation groups. The percentages of abnormal eggs were 5.3%, 5.6% and 6.4% in the groups with one, two or three induced ovulations, respectively ( Table 2 ). These percentages were not statistically significant, compared with the intact control group.
DISCUSSION
To induce ovulation in hamsters a dose of 20 -30 IV hCG has been administered conventionally." In a previous study we showed that when ovulation is induced by this dose of hCG more than 20% of the ovulated eggs are abnormal, showing cleavage, although unfertilized, and that the percentage of abnormal eggs was higher than 30% when ovulation was induced repeatedly (three times)." Experiment 1 in the present study demonstrated that 5 IV hCG is sufficient for the induction of ovulation in hamsters. Even when ovulation was induced using this low dose of hCG, 5.3% of the ovulated eggs were abnormal, which was higher than the percentage in the control group (1.7%) but markedly lower than that when ovulation was induced with 30 IU hCG (20%) in our previous study: As shown in Table 2 , the percentages of abnormal eggs were slightly increased by repeatedly inducing ovulation (up to three times), but the differences were not statistically significant.
TABLE 1
Determination of the minimum dose of human chorionic gonadotrophin (hCG) required to induce ovulation in hamsters whose ovulation was blocked by phenobarbitone injection
We have already shown that in repeatedly induced ovulation in mice":' and hamsters 4 using gonadotrophin, abnormal unfertilized eggs showing cleavage are often observed in the oviduct. The results of experiments using animals suggest that the low rate of pregnancy in women repeatedly given gonadotrophin for the treatment of an ovulation disorder might result from abnormalities of the ovulated eggs.
The results of the present study suggest that the marked increase in numbers of abnormal eggs produced in repeatedly induced ovulation in the studies reported' -5 can be greatly reduced, by using the minimum dose of gonadotrophin effective for ovulation.
